These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pacing and sensing optimization of permanent His-bundle pacing in cardiac resynchronization therapy/implantable cardioverter defibrillators patients: value of integrated bipolar configuration. Su L; Xu L; Wu SJ; Huang WJ Europace; 2016 Sep; 18(9):1399-405. PubMed ID: 26581403 [TBL] [Abstract][Full Text] [Related]
8. Implantable cardiac electronic device therapy for patients with a systemic right ventricle. Barracano R; Brida M; Guarguagli S; Palmieri R; Diller GP; Gatzoulis MA; Wong T Heart; 2020 Jul; 106(14):1052-1058. PubMed ID: 32269130 [TBL] [Abstract][Full Text] [Related]
9. Optimal pacing for right ventricular and biventricular devices: minimizing, maximizing, and right ventricular/left ventricular site considerations. Gillis AM Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):968-77. PubMed ID: 25336367 [TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation reduces the atrial impedance amplitude during cardiac cycle: a novel detection algorithm to improve recognition of atrial fibrillation in pacemaker patients. Schmidt B; Asbach S; Schweika O; Zehender M; Bode C; Faber TS Europace; 2007 Sep; 9(9):812-6. PubMed ID: 17545214 [TBL] [Abstract][Full Text] [Related]
12. Hyperkalaemic cardiac arrhythmia with pacemaker/implantable cardioverter-defibrillator action disturbance. La Rocca R; Materia V; Falliano MF; Sciacca N; Marte F; Patanè S Int J Cardiol; 2012 May; 156(3):e49-50. PubMed ID: 20537419 [No Abstract] [Full Text] [Related]
13. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Groh CA; Sharma S; Pelchovitz DJ; Bhave PD; Rhyner J; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP Heart Rhythm; 2014 Aug; 11(8):1361-6. PubMed ID: 24755323 [TBL] [Abstract][Full Text] [Related]
14. Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring. Nishii N; Miyoshi A; Kubo M; Miyamoto M; Morimoto Y; Kawada S; Nakagawa K; Watanabe A; Nakamura K; Morita H; Ito H J Cardiovasc Electrophysiol; 2018 Mar; 29(3):463-470. PubMed ID: 29194831 [TBL] [Abstract][Full Text] [Related]
15. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338 [TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation. Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943 [TBL] [Abstract][Full Text] [Related]
17. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Spencker S; Coban N; Koch L; Schirdewan A; Müller D Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654 [TBL] [Abstract][Full Text] [Related]
18. A review of specialized and automated features in implantable cardiac devices. Ayinde H; Lloyd M J Cardiovasc Electrophysiol; 2020 Jan; 31(1):271-285. PubMed ID: 31724786 [TBL] [Abstract][Full Text] [Related]
20. Should stimulation therapy for congestive heart failure be combined with defibrillation backup? Gaita F; Bocchiardo M; Porciani MC; Vivalda L; Colella A; Di Donna P; Caponi D; Bruzzone M; Padeletti L Am J Cardiol; 2000 Nov; 86(9A):165K-158K. PubMed ID: 11084118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]